Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Distributors Need Notice Of Manufacturers’ Accounting Changes, HDMA Says

Executive Summary

Drug manufacturers implementing changes to their accounting practices should remember that there could be "serious consequences" for wholesalers, Healthcare Distribution Management Association President Ron Streck said

You may also be interested in...



Wholesalers Seek Rx Coalition To Create Product Tracking System

Drug wholesalers are putting together a coalition with industry and FDA representatives to work on product identification and patient safety issues

Wholesalers Seek Rx Coalition To Create Product Tracking System

Drug wholesalers are putting together a coalition with industry and FDA representatives to work on product identification and patient safety issues

Wholesaler Task Force Looking At Shortages, Forward-Buying

The Healthcare Distribution Management Association's Drug Availability Task Force is developing industry guidelines to help alleviate the problem of year-end drug shortages

Related Content

UsernamePublicRestriction

Register

PS040762

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel